Engineering cells for solid tumor therapy
Trends in Pharmacological Sciences · 2026-08 · 47 (8) · 855-870
DOI: 10.1016/j.tips.2026.06.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-08. Verfasst von Yuyang Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Cell Engineering, Cell- and Tissue-Based Therapy. Die Arbeit nennt 116 Literaturangaben. Gefördert von: Natural Science Research of Jiangsu Higher Education Institutions of China, Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Living cell therapy and nonliving drugs are both key approaches for treating solid tumors. Engineering living cells with nonliving drugs harnesses their complementary advantages to enhance therapeutic outcomes. However, inappropriate engineering methods or design strategies can compromise the synergy between cells and drugs. In this review, we provide a decision framework that matches engineering strategies to cell types and drug properties, yielding baseline-qualified engineered cells. To address barriers specific to solid tumors, we then discuss strategies for equipping cells with additional functions that enable deeper penetration, resistance to immunosuppression, and controlled release. We also discuss emerging strategies to increase their safety during clinical translation. This review aims to guide the rational design of next-generation engineered cell therapies to achieve improved clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Technology, School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China.
- State Key Laboratory of Microbial Technology, School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China. Electronic address: wuln@njnu.edu.cn.
- State Key Laboratory of Microbial Technology, School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China. Electronic address: liyanan@njnu.edu.cn.
- State Key Laboratory of Microbial Technology, School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech Univers…
- State Key Laboratory of Microbial Technology, School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China. Electronic address: huangh@njnu.edu.cn.
- State Key Laboratory of Microbial Technology, School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China. Electronic address: mlt@njnu.edu.cn.
Förderung
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
Zitieren
APA
Xiao, Y., Wu, Y., Cao, Q., Wu, L., Li, Y., Yang, G., Huang, H., & Meng, L. (2026). Engineering cells for solid tumor therapy. Trends in Pharmacological Sciences, 47(8), 855-870. https://doi.org/10.1016/j.tips.2026.06.002
Vancouver
Xiao Y, Wu Y, Cao Q, Wu L, Li Y, Yang G, et al. Engineering cells for solid tumor therapy. Trends in Pharmacological Sciences. 2026;47(8):855-870. doi:10.1016/j.tips.2026.06.002
BibTeX
@article{Xiao2026,
author = {Xiao, Yuyang and Wu, Yue and Cao, Qinyan and Wu, Lina and Li, Yanan and Yang, Guang and Huang, He and Meng, Lingtong},
title = {Engineering cells for solid tumor therapy},
journal = {Trends in Pharmacological Sciences},
year = {2026},
volume = {47},
number = {8},
pages = {855--870},
doi = {10.1016/j.tips.2026.06.002}
}
EUVIMED